Perspectives of Artificial Intelligence Enabled Diagnosis and Treatment Management of Cardiorenal Syndrome
Journal of CardioRenal Medicine · 31.10.2026 · 2 (4) · 12
DOI: 10.3390/jcrm2040012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of CardioRenal Medicine, online erschienen am 31.10.2026. Verfasst von Harsha Pudhota und 25 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiorenal syndrome (CRS) encompasses a spectrum of disorders arising from bidirectional interactions between the heart and kidneys and is associated with substantial morbidity, mortality, and healthcare burden. Early recognition remains challenging because conventional biomarkers and imaging modalities may inadequately detect subclinical disease or distinguish functional changes from true organ injury. This narrative review examines the epidemiology, classification, pathophysiology, diagnostic approaches, and contemporary management of CRS, with particular emphasis on the emerging role of artificial intelligence (AI). Relevant evidence regarding established and emerging diagnostic and therapeutic approaches was reviewed, including biomarkers, imaging, guideline-directed medical therapy, ultrafiltration, cardiac devices, transplantation, and AI-based applications. Current evidence demonstrates the multifactorial nature of CRS and highlights the importance of early diagnosis and individualized management. Machine learning and deep learning approaches have shown potential to integrate electronic health records, biomarkers, imaging, physiological signals, and multi-omics data to support early detection, risk stratification, outcome prediction, and therapeutic decision-making. AI-assisted approaches may complement conventional diagnostic and management strategies and facilitate more precise and proactive CRS care. However, limitations related to data quality, model interpretability, external validation, and clinical implementation must be addressed before widespread clinical adoption.
Zitieren
APA
Pudhota, H., Panjwani, G. A. R., Sahito, A. F., Goudel, A., Pant, P., Gogula, N. S. A. R., Pachchipulusu, V., Saraboji, K., Bumrah, S. K., Kaur, A., Farook, F., Yadav, J., Lee, J., Shariff, M. N., Yerrapragada, G., Elangovan, P., Wilson, S. M. J., Virmani, M., Karuppiah, S. S., …, & Arunachalam, S. P. (2026). Perspectives of Artificial Intelligence Enabled Diagnosis and Treatment Management of Cardiorenal Syndrome. Journal of CardioRenal Medicine, 2(4), 12. https://doi.org/10.3390/jcrm2040012
Vancouver
Pudhota H, Panjwani GAR, Sahito AF, Goudel A, Pant P, Gogula NSAR, et al. Perspectives of Artificial Intelligence Enabled Diagnosis and Treatment Management of Cardiorenal Syndrome. Journal of CardioRenal Medicine. 2026;2(4):12. doi:10.3390/jcrm2040012
BibTeX
@article{Pudhota2026,
author = {Pudhota, Harsha and Panjwani, Gianeshwaree Alias Rachna and Sahito, Areesh Fatima and Goudel, Aastha and Pant, Prashant and Gogula, Naga Sai Akhil Reddy and Pachchipulusu, Vamsi and Saraboji, Kaaviyashri and Bumrah, Simardeep Kaur and Kaur, Anmolpreet and Farook, Farshi and Yadav, Jyoti and Lee, Jieun and Shariff, Mohammed Naveed and Yerrapragada, Gayathri and Elangovan, Poonguzhali and Wilson, Sancia Mary Jerold and Virmani, Mini and Karuppiah, Shiva Sankari and Shivaram, Suganti and Sood, Divyanshi and Pugalenthi, Lakshmi Sree and Bilgaiyan, Rashi and Rapolu, Swetha and Helgeson, Scott A. and Arunachalam, Shivaram P.},
title = {Perspectives of Artificial Intelligence Enabled Diagnosis and Treatment Management of Cardiorenal Syndrome},
journal = {Journal of CardioRenal Medicine},
year = {2026},
volume = {2},
number = {4},
pages = {12},
doi = {10.3390/jcrm2040012}
}
EUVIMED